Are you currently facing hurdles in your flavivirus research, such as cross-reactivity within the Japanese encephalitis virus serocomplex, low neutralization potency in assay development, or a lack of reliable structural probes? Creative Biolabs'MVEV Env specific Neutra™ antibody products help you achieve high-affinity, validated results and accelerate your therapeutic pipeline through our advanced hybridoma technology and innovative protein engineering platforms.
Murray Valley encephalitis virus Envelope protein (MVEV Env) is the principal surface glycoprotein of the Murray Valley encephalitis virus, a member of the Flaviviridae family. As the primary target of the host immune system, MVEV Env is essential for the virus's ability to infect host cells. It is expressed as a precursor (prM-E) during viral maturation and is eventually cleaved to form the mature, infectious virion surface.
The architecture of MVEV Env is characterized by a head-to-tail homodimeric arrangement on the mature viral membrane. Each monomer is composed of three distinct beta-sheet rich domains: Domain I (DI), the central structural scaffold; Domain II (DII), which contains the highly conserved internal fusion loop; and Domain III (DIII), an immunoglobulin-like fold that protrudes from the viral surface. This domain-based structure is critical for the protein's ability to undergo the dramatic conformational shifts required for membrane fusion.
Fig.1 The ectodomain of the MVEV Env protein and the locations of amino acids.1
The primary function of MVEV Env is to facilitate viral entry into the host cell. It mediates initial attachment to specific cell-surface receptors and, following endocytosis, orchestrates the fusion of the viral envelope with the endosomal membrane. This fusion is triggered by the acidic environment of the endosome, causing the Env dimers to reorganize into stable trimers, which expose the fusion peptide and allow the viral genome to enter the cytoplasm.
MVEV Env is the critical factor in the pathogenesis of Murray Valley Encephalitis (MVE). This disease ranges from mild febrile illness to severe, potentially fatal neuroinvasive disease characterized by encephalitis, permanent neurological sequelae, and high mortality rates in symptomatic patients.
Neutralizing antibodies targeting the MVEV Env DIII are being investigated as potent passive immunotherapies. By blocking the receptor-binding site, these antibodies prevent viral attachment, significantly reducing viral load and preventing neuroinvasion in pre-clinical models.
Due to the high sequence homology among flaviviruses, anti-MVEV Env antibodies are essential for developing IgM-capture ELISAs and lateral flow immunochromatographic assays that can accurately differentiate MVEV from West Nile or Kunjin viruses.
In vaccine development, MVEV Env antibodies serve as the "gold standard" reagents in Plaque Reduction Neutralization Tests (PRNT). They allow researchers to quantify the neutralizing breadth of the vaccine-induced immune response and identify correlates of protection.
Researchers utilize these antibodies to perform escape mutant analysis. By identifying which residues on MVEV Env allow the virus to bypass neutralization, scientists can better understand viral evolution and design more robust, "escape-proof" immunogens.
Neutralizing antibodies are integrated into biosensors for environmental monitoring. These tools allow for the rapid detection of MVEV in mosquito populations (e.g., Culex annulirostris), providing critical data for public health authorities to implement timely vector control measures.
By labeling anti-MVEV Env antibodies with fluorescent markers, scientists can track the movement of the virus through the blood-brain barrier and into specific neural pathways, providing insights into how the virus causes cerebral inflammation.
These antibodies are used as "chaperones" in Cryo-EM and X-ray crystallography to stabilize specific conformational states of the MVEV Env protein, revealing the molecular details of the fusion process.
Creative Biolabs provides a comprehensive catalog of high-performance antibodies specifically designed to target the MVEV Env protein with unparalleled affinity. Our selection includes diverse clones that have been rigorously validated across multiple platforms to ensure reliability in both basic research and clinical development settings.
Creative Biolabs remains your premier partner for high-quality MVEV Env specific Neutra™ antibody products, offering the precision and reliability needed to overcome the complexities of flavivirus research. For detailed technical specifications, bulk pricing, or to discuss a custom project, please contact our team today—our experts are ready to provide a prominent consultation to help you achieve your research goals.
Reference
Recombinant Anti-MVEV Env Antibody (V3S-1022-YC4728) (CAT#: V3S-1022-YC4728)
Target: MVEV Env
Host Species: Mouse
Target Species: Murray Valley encephalitis virus (MVEV),
Application: WB,